































	 Synthesis	 of	 ethyl	 6‐(8‐hydroxyquinolin‐5‐yl)‐3‐methylpyridazin‐4‐carboxylate	 (4)	 via	 one‐
pot	 three	 component	 reaction	 of	 ethyl	 acetoacetate	 with	 (8‐hydroxyquinolin‐5‐yl)(oxo)
acetaldehyde	 (2)	 in	 the	 presence	 of	 hydrazine	 hydrate	 at	 room	 temperature	 in	 water	 was
described.	A	new	series	of	heterocyclic	moieties	such	as	oxadiazoles,	triazoles,	pyrazoles	and
Schiff	 bases	 were	 prepared	 and	 characterized.	 The	 structures	 of	 the	 newly	 synthesized
compounds	 were	 established	 by	 elemental	 and	 spectral	 data.	 The	 antimicrobial	 activity	 of
some	of	 the	 synthesized	compounds	was	examined	against	 two	Gram‐positive	bacteria,	 two











Various	 pyridazine‐annulated	 heterocycles	 have	 been	
attracted	 considerable	 interest	 because	 their	 derivatives	
exhibit	a	wide	range	of	pharmacological	activities	[1‐4].	A	subs‐
tantial	 number	 of	 pyridazines	 have	 been	 reported	 to	 possess	
and	 are	 often	 employed	 as	potent	 analgesic	 [5],	 antimicrobial	
[6,7],	 anti‐inflammatory	 [8],	 antioxidant	 [9],	 antiplatelet	 [10],	
anticancer	 [11],	 anticonvulsant	 [12],	 antifeedant	 [13],	 anti‐
hypertensive	[14],	and	antidiabetic	[15].	Moreover,	pyridazines	
are	 useful	 intermediates	 in	 the	 construction	 of	 several	 other	
heterocycles	[16,17].	With	all	the	above	facts	in	mind	and	as	a	
part	 of	 our	 program	 directed	 towards	 the	 synthesis	 of	 poly‐
functionalized	 substituted	 5‐heterocyclo‐8‐hydroxyquinolines	
of	potential	biologically	interest	[18‐22],	we	have	devoted	some	
efforts	 to	 the	 construction	 of	 a	 novel	 ethyl	 6‐(8‐hydroxy	
quinolin‐5‐yl)‐3‐methylpyridazin‐4‐carboxylate	 (4)	 as	 a	 con‐
veniently	 accessible	 precursor	 for	 the	 synthesis	 of	 some	
hitherto	unreported	substituted	8‐quinolinolinyl‐5‐pyridazines	











MHz	 for	 1H	 and	 50	 MHz	 for	 13C)	 at	 the	 Faculty	 of	 Science,	
University	 of	 King	 Saud,	 Saudi	Arabia,	 Riyadh	 and	 on	 a	 Jeol	 a	
400	MHz	 (400	MHz	 for	 1H	and	100	MHz	 for	 the	 13C)	at	Assiut	
University	using	CDCl3	and	DMSO‐d6	as	solvents.	Mass	spectra	
were	 taken	 on	 a	 JEOL	 JMS600	 spectrometer	 at	 an	 ionizing	
potential	of	70	eV	(EI)	at	Assiut	University.	Elemental	analyses	
were	recorded	on	Gmbh	VarioEL	V2.3	Micro	analyzer	at	Assiut	



















5‐Acetyl‐8‐hydroxyquinoline	 (1)	 (2.21	 g,	 10	 mmol)	 and	 SeO2	
(5.55	g,	50	mmol)	were	dissolved	 in	a	mixture	of	dioxane	(80	
mL)	and	water	 (5	mL)	and	 refluxed	 for	8	h.	After	 filtration	of	
the	 black	 selenium	 powder,	 the	 clear	 filtrate	 as	 concentrated	
nearly	 to	 dryness.	 Toluene	 (40	 mL)	 was	 added,	 the	 reaction	
mixture	 was	 refluxed	 for	 2	 h,	 decanted	 from	 the	 remaining	
residue	 and	 the	 solvents	 were	 evaporated	 to	 leave	 yellow	
needles	 after	 cooling.	 The	 crystals	 were	 filtered	 off,	 washed	
with	 small	 amount	 of	 ethanol,	 dried	 and	 crystallized	 from	
ethanol	 to	 give	 compound	2	 (Scheme	1).	 Color:	 Yellow.	 Yield:	
62%.	M.p.:	139‐141	°C.	FT‐IR	(KBr,	ν,	cm−1):	1676,	(C=O),	1665	
(HC=O).	 1H	 NMR	 (200	MHz,	 DMSO‐d6,	 δ,	 ppm):	 7.03‐8.81	 (m,	
6H,	5	Ar‐H,	OH),	10.12	(s,	1H,	CHO).	13C	NMR	(100	MHz,	DMSO‐
d6,	 δ,	 ppm):	 201.1,	 189.6,	 155.7,	 154.3,	 150.3,	 148.7,	 144.4,	
129.9,	128.8,	125.4,	115.3.	MS	(EI,	m/z	 (%)):	201.23	(M+.,	75).	






To	 a	mixture	 of	 compound	2	 (4.02	 g,	 20	mmol)	 and	 ethyl	
acetoacetate	(2.6	g,	20	mmol)	in	water	(60	mL),	was	gradually	
added	hydrazine	hydrate	(10	mmol)	at	room	temperature;	the	
resultant	 mixture	 was	 stirred	 for	 1	 h.	 During	 which	 time,	 a	
precipitate	was	formed,	and	then	it	was	filtered	off	and	washed	
with	water.	The	crude	product	was	purified	by	recrystallization	
from	 ethanol	 to	 give	 compound	4	 (Scheme	 1).	 Color:	 Yellow.	
Yield:	82%.	M.p.:	177‐179	°C.	FT‐IR	(KBr,	ν,	cm−1):	2980,	2885	
(CH‐	 aliphatic),	 1732	 (C=O),	 1620	 (C=N).	 1H	 NMR	 (200	MHz,	
DMSO‐d6,	δ,	ppm):	1.35	(t,	J	=	7.4	Hz,	3H,	CH3),	3.15	(s,	3H,	CH3),	
4.25	 (q,	 J	 =	 7.4	 Hz,	 2H,	 CH2),	 7.25‐8.80	 (m,	 7H,	 5	 Ar‐H,	 CH‐
pyridazine,	OH).	 13C	NMR	(100	MHz,	DMSO‐d6,	δ,	ppm):	169.2,	
155.3,	 152.2,	 150.4,	 148.4,	 140.8,	 139.6,	 129.3,	 127.2,	 125.5,	







To	 a	 suspension	 of	 compound	 4	 (3.09	 g,	 10	 mmol)	 in	
ethanol	(30	mL),	hydrazine	hydrate	(20	mmol)	was	added	and	
the	mixture	was	 heated	 under	 reflux	 for	 4	 h.	 The	 precipitate	
was	 collected	 by	 filtration	 and	 recrystallized	 from	 ethanol	 to	
give	 compound	8	 (Scheme	2).	Color:	Yellow.	Yield:	80%.	M.p.:	
303‐305	°C.	FT‐IR	(KBr,	ν,	cm−1):	3400,	3350,	3200	(NH2,	NH),	
2995	 (CH‐aliphatic),	 1665	 (C=O),	 1620	 (C=N).	 1H	 NMR	 (200	
MHz,	CDCl3,	δ,	ppm):	2.95	(s,	3H,	CH3),	4.42	(s,	2H,	NH2),	7.30‐
8.89	(m,	7H,	5	Ar‐H,	CH‐pyridazine,	OH),	10.14	(s,	1H,	NH).	13C	
NMR	 (100	MHz,	DMSO‐d6	 δ,	 ppm):	 166.6,	 159.2,	 156.1,	146.4,	








A	 mixture	 of	 acid	 hydrazide	 (8)	 (2.95	 g,	 10	 mmol),	
potassium	hydroxide	(0.56	g,	10	mmol),	carbon	disulfide	(1.29	
g,	17	mmol),	and	ethanol	(70	mL)	was	heated	under	reflux	with	
stirring	 until	 the	 evolution	 of	 hydrogen	 sulfide	 ceased	 (9	 h).	
Ethanol	 was	 distilled	 off	 under	 reduced	 pressure	 and	 the	
residue	was	 dissolved	 in	water	 and	 then	 acidified	with	 dilute	
hydrochloric	acid	(10%).	The	resulting	precipitate	was	filtered,	
washed	with	water,	 dried,	 and	 recrystallized	 from	 ethanol	 to	
give	 compound	9	 (Scheme	2).	Color:	Yellow.	Yield:	69%.	M.p.:	
216‐218	 °C.	 FT‐IR	 (KBr,	 ν,	 cm−1):	 3250	 (NH),	 2990	 (CH‐
aliphatic),	1365	(C=S),	1620	(C=N).	1H	NMR	(400	MHz,	DMSO‐
d6,	 δ,	 ppm):	 3.05	 (s,	 3H,	 CH3),	 7.25‐8.85	 (m,	 7H,	 5	 Ar‐H,	 CH‐
pyridazine,	OH),	10.14	(s,	1H,	NH).	 13C	NMR	(100	MHz,	DMSO‐








A	 mixture	 of	 compound	 9	 or	 13	 (5	 mmol),	 ethyl	 iodide	







3‐yl)quinolin‐8‐ol	 (10a):	 Color:	 Yellow.	 Yield:	 72%.	 M.p.:	 132‐
134	°C.	FT‐IR	(KBr,	ν,	cm−1):	2980	(CH‐	aliphatic),	1625	(C=N).	
1H	NMR	 (200	MHz,	DMSO‐d6,	 δ,	 ppm):	 1.20	 (t,	 J	=	7.4	Hz,	 3H,	
CH3),	2.99	(s,	3H,	CH3),	3.65	(q,	 J	=	7.4	Hz,	2H,	CH2),	7.18‐8.75	
(m,	7H,	5	Ar‐H,	CH‐pyridazine,	OH).	13C	NMR	(100	MHz,	DMSO‐
d6,	 δ,	 ppm):	 162.3,	 154.4,	 151.2,	 146.2,	 138.0,	 130.4,	 127.8,	
125.5,	 124.4,	 123.2,	 120.0,	 115.7,	 113.7,	 112.3,	 111.19,	 28.6,	




147‐149	 °C.	 FT‐IR	 (KBr,	 ν,	 cm−1):	 2980	 (CH‐	 aliphatic),	 1625	
(C=N).	1H	NMR	(200	MHz,	DMSO‐d6,	δ,	ppm):	3.03	(s,	3H,	CH3),	
4.15	 (s,	 2H,	 CH2),	 6.99‐8.88	 (m,	 12H,	 10	 Ar‐H,	 CH‐pyridazine,	
OH).	13C	NMR	(100	MHz,	DMSO‐d6,	δ,	ppm):	161.7,	155.0,	150.5,	
148.8,	 137.5,	 129.1,	 128.3,	 127.5,	 126.2,	 125.3,	 124.6,	 123.7,	
122.1,	 120.2,	 120.0,	 119.6,	 118.4,	 116.7,	 115.6,	 115.3,	 113.4,	
36.7,	 18.2.	 Anal.	 calcd.	 for	 C23	 H17N5O2S:	 C,	 64.62;	 H,	 4.01;	 N,	
16.38.	Found:	C,	64.83;	H,	4.35;	N,	16.66%.	
5‐(5‐(5‐(Ethylthio)‐4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐6‐methyl	
pyridazin‐3‐yl)quinolin‐8‐ol	 (14a):	 Color:	 Yellow.	 Yield:	 79%.	
M.p.:	 170‐172	 °C.	 FT‐IR	 (KBr,	 ν,	 cm−1):	 2900	 (CH‐aliphatic),	
1625	(C=N),	1360	(C=S).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	
1.31	(t,	J	=	7.4	Hz,	3H,	CH3),	2.80	(s,	3H,	CH3),	3.85	(q,	J	=	7.4	Hz,	
2H,	CH2),	6.85‐8.60	 (m,	 12H,	10	Ar‐H,	CH‐pyridazine,	OH).	 13C	
NMR	(100	MHz,	DMSO‐d6,	 δ,	ppm):	157.6,	156.2,	153.4,	149.0,	
148.4,	 140.6,	 138.1,	 136.6,	 130.9,	 130.1,	 129.5,	 128.3,	 127.0,	
126.7,	 126.1,	 125.9,	 123.5,	 120.2,	 116.7,	 113.3,	 112.7	 ,	 30.3,	













































a, R = N O
c, R = NH-C6H4(4-OCH3)
b, R = NH-C6H5














methylpyridazin‐3‐yl)quinolin‐8‐ol	 (14b):	 Color:	 Yellow.	 Yield:	
61%.	 M.p.:	 188‐190	 °C.	 FT‐IR	 (KBr,	 ν,	 cm−1):	 2950	 (CH‐
aliphatic),	1625	(C=N),	1420	(C=S).	1H	NMR	(400	MHz,	DMSO‐







Formalin	 40%	 (1.5	mL,	 20	mmol)	was	 added	 to	 a	 stirred	
solution	of	 compound	9	or	13	 (20	mmol)	 in	 absolute	 ethanol	
(40	 mL).	 An	 ethanolic	 solution	 (10	 mL)	 of	 the	 appropriate	
amine	 (20	 mmol)	 was	 added	 portion	 wise	 to	 the	 reaction	
mixture,	stirred	for	3	h	at	room	temperature,	and	left	overnight	
in	 a	 refrigerator.	 The	precipitate	 formed	was	filtered,	washed	
with	cold	ethanol,	dried,	and	crystallized	from	ethanol	to	afford	




Color:	 Yellow.	 Yield:	 60%.	 M.p.:	 187‐189	 °C.	 FT‐IR	 (KBr,	 ν,	
cm−1):	 2990	 (CH‐aliphatic),	 1625	 (C=N),	 1350	 (C=S).	 1H	 NMR	
(200	MHz,	DMSO‐d6,	δ,	ppm):	2.99	(s,	3H,	CH3),	3.15	(t,	 J	=	7.4	
Hz,	4H,	2CH2),	3.65	 (t,	 J	=	7.4	Hz,	4H,	2CH2),	5.12	(s,	2H,	CH2),	
7.25‐8.78	 (m,	 7H,	 5	 Ar‐H,	 CH‐pyridazine,	 OH).	 13C	 NMR	 (100	
MHz,	 DMSO‐d6,	 δ,	 ppm):	 178.8,	 158.7,	 155.6,	 150.9,	 146.3,	
139.5,	 130.3,	 127.6,	 126.3,	 125.2,	 124.7,	 122.3,	 116.4,	 114.8,	





cm−1):	 3235	 (NH),	 2990	 (CH‐aliphatic),	 1635	 (C=N),	 1360	
(C=S).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	2.85	(s,	3H,	CH3),	
5.18	(s,	1H,	NH),	5.45	(d,	J	=	7.4	Hz,	2H,	CH2),	6.95‐8.75	(m,	12H,	















1H	 NMR	 (400	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 2.95	 (s,	 3H,	 CH3),	
3.79	(s,	3H,	OCH3),	5.30	(d,	J	=	7.4	Hz,	2H,	CH2),	5.85	(s,	1H,	NH),	
6.85‐8.80	(m,	11H,	9	Ar‐H,	CH‐pyridazine,	OH).	Anal.	calcd.	for	





ν,	 cm−1):	 3245	 (NH),	 2880	 (CH‐aliphatic),	 1630	 (C=N),	 1360	
(C=S).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	3.05	(s,	3H,	CH3),	
5.30	(s,	1H,	NH),	5.55	(d,	J	=	7.4	Hz,	2H,	CH2),	6.95‐8.90	(m,	11H,	














ν,	 cm−1):	 3320	 (NH),	 2990,	 2895	 (CH‐aliphatic),	 1620	 (C=N),	
1330	(C=S).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	2.80	(s,	3H,	
CH3),	5.20	 (s,	 1H,	NH),	5.60	 (d,	 J	=	7.4	Hz,	2H,	CH2),	6.90‐8.80	
(m,	 17H,	 15	 Ar‐H,	 CH‐pyridazine,	 OH).	 13C	 NMR	 (100	 MHz,	
DMSO‐d6,	 δ,	 ppm):	 165.5,	 159.4,	 158.8,	 157.2,	 155.5,	 154.3,	
150.6,	 148.1,	 146.4,	 144.7,	 140.8,	 139.5,	 138.7,	 136.4,	 130.3,	






FT‐IR	 (KBr,	 ν,	 cm−1):	 3330	 (NH),	 2990,	 2895	 (CH‐aliphatic),	
1630	(C=N),	1330	(C=S).	1H	NMR	(400	MHz,	DMSO‐d6,	δ,	ppm):	
2.90	(s,	3H,	CH3),	3.80	(s,	3H,	OCH3),	4.95	(s,	1H,	NH),	5.65	(d,	J	=	
7.4	 Hz,	 2H,	 CH2),	 6.95‐8.85	 (m,	 16H,	 14	 Ar‐H,	 CH‐pyridazine,	






























A	 mixture	 of	 hydrazide	 (8)	 (1.48	 g,	 5	 mmol)	 and	 phenyl	









153.3,	 149.2,	 148.7,	 145.2,	 138.7,	 130.1,	 129.1,	 126.6,	 125.6,	
125.0,	 124.9,	 123.8,	 120.3,	 118.5,	 115.3,	 113.2,	 112.4,	 112.9,	








sodium	 hydroxide	 solution	 (5%,	 25	 mL)	 was	 heated	 under	
reflux	 for	 1	 h.	 The	 reaction	mixture	was	 allowed	 to	 cool	 and	
























To	 a	 solution	 of	 compound	 8	 (0.59	 g,	 2	 mmol)	 in	 glacial	
acetic	acid	 (15	mL),	was	added	acetylacetone	 (0.2	g,	2	mmol).	
The	reaction	mixture	was	heated	under	reflux	for	8	h,	and	then	
allowed	 to	 cool	 to	 room	 temperature.	 The	 solid	 product	 thus	
formed	 was	 filtered,	 thoroughly	 washed	 with	 cold	 ethanol,	







7H,	 5	 Ar‐H,	 CH‐pyridazine,	 OH).	 13C	 NMR	 (100	MHz,	 CDCl3,	 δ,	
ppm):	 166.2,	 159.2,	 150.7,	 148.3,	 140.5,	 137.6,	 134.8,	 130.5,	









oil	 bath	 for	 2	 h.	 After	 being	 cooled	 to	 room	 temperature,	 the	
solidified	product	was	treated	with	cold	diethyl	ether,	filtered,	
washed	 with	 diethyl	 ether,	 dried	 and	 recrystallized	 from	
aqueous	ethanol	to	give	compound	18	(Scheme	4).	Color:	Pale	
light.	Yield:	48%.	M.p.:	241‐243	 °C.	FT‐IR	 (KBr,	 ν,	 cm−1):	3250	
(NH),	 1720	 (C=O),	 1700	 (C=O),	 1675	 (C=O),	 1620	 (C=N).	 1H	
NMR	(200	MHz,	CDCl3,	δ,	ppm):	2.79	 (s,	3H,	CH3),	3.50	 (s,	2H,	







A	mixture	of	 compound	8	 (10	mmol)	 and	 the	appropriate	
aromatic	 aldehyde	 (10	 mmol)	 was	 stirred	 under	 reflux	 in	
ethanol	(30	mL)	in	the	presence	of	a	few	drops	of	piperidine	for	
5	 h.	 The	 reaction	 mixture	 was	 allowed	 to	 cool	 to	 room	
temperature,	 poured	 into	water,	whereby	 a	 solid	 formed	 that	
was	 filtered	 off	 and	 crystallized	 from	 an	 appropriate	 solvent	
(Scheme	4).	
6‐(8‐Hydroxyquinolin‐5‐yl)‐N'‐[phenylmethylidene]‐3‐methyl	





D2O‐exchangeable).	 Anal.	 calcd.	 for	 C22H17N5O2:	 C,	 68.92;	 H,	
4.47;	N,	18.27.	Found:	C,	69.16;	H,	4.63;	N,	18.41%.	
6‐(8‐Hydroxyquinolin‐5‐yl)‐N'‐[4‐chlorophenylmethylidene]‐
3‐methylpyridazine‐4‐carbohydrazide	 (19b):	 Color:	 Pale	 light	
yellow	from	dioxane.	Yield:	60%.	M.p.:	266‐268	°C.	FT‐IR	(KBr,	
ν,	 cm−1):	 3320	 (NH),	 1685	 (C=O),	 1640	 (C=N).	 1H	 NMR	 (400	
MHz,	DMSO‐d6,	δ,	ppm):	2.77	(s,	3H,	CH3),	6.95‐8.65	(m,	11H,	9	
Ar‐H,	 CH‐pyridazine,	OH),	 9.15	 (s,	 1H,	 CH	azomethene),	 11.25	
(s,	 1H,	NH	D2O‐exchangeable).	MS	 (EI,	m/z	 (%)):	 417.84	 (M+.,	
61).	 Anal.	 calcd.	 for	 C22H16ClN5O2:	 C,	 63.24;	 H,	 3.86;	 N,	 16.76.	
Found:	C,	63.58;	H,	4.09;	N,	18.98%.	
6‐(8‐Hydroxyquinolin‐5‐yl)‐N'‐[4‐methoxyphenyl	 methylide	
ne]‐3‐methyl	 pyridazine‐4‐carbohydrazide	 (19c):	 Color:	 Pale	
white	from	dioxane.	Yield:	59%.	M.p.:	310‐312	°C.	FT‐IR	(KBr,	ν,	











A	 solution	of	 the	acid	hydrazide	 (8)	 (0.59	g,	 2	mmol)	 and	
isatin	(0.29	g,	2	mmol)	in	glacial	acetic	acid	(10	mL)	was	heated	
under	 reflux	 for	 2	 h,	 during	 which	 a	 deep	 yellow	 solid	 was	
partially	crystallized	out.	The	solid	separated	upon	cooling	was	




ppm):	 2.65	 (s,	 3H,	 CH3),	 6.85‐8.80	 (m,	 11H,	 9	 Ar‐H,	 CH‐
pyridazine,	OH),	9.15	(s,	1H,	NH),	9.33	(s,	1H,	NH).	Anal.	calcd.	









g,	 2.5	mmol)	 in	 glacial	 acetic	 acid	 (15	mL)	was	 heated	 under	
reflux	 for	 10	 h.	 The	 reaction	 mixture	 was	 concentrated	 in	
vacuum	to	half	its	volume	and	allowed	to	cool.	The	precipitated	
solid	product	was	filtered,	washed	with	cold	ethanol,	dried	and	
recrystallized	 from	 acetic	 acid	 to	 give	 compound	21	 (Scheme	
4).	 Color:	 Yellow.	Yield:	 55%.	M.p.:	 173‐175	 °C.	 FT‐IR	 (KBr,	 ν,	








The	 antimicrobial	 activity	 of	 13	 selected	 compounds	 was	
evaluated	 against	 four	 bacterial	 and	 four	 fungal	 strains.	 All	
microbial	strains	were	kindly	provided	by	the	Assiut	University	
Mycological	 Centre	 (AUMC).	 These	 strains	 are	 common	
contaminants	of	 the	environment	 in	Egypt	and	some	of	which	
are	involved	human	and	animal	diseases	(Trichophyton	rubrum,	
Candida	 albicans,	 Geotrichum	 candidum,	 Scopulariopsis	 brevi‐
caulis,	Aspergillus	flavus),	plant	diseases	(Fusarium	oxysporum)	
or	frequently	reported	from	contaminated	soil,	water	and	food	
substances	 (Escherichia	 coli,	 Bacillus	 cereus,	 Pseudomonas	
aeruginosa,	 Serratia	 marcescens,	 Staphylococcus	 aureus,	
Micrococcus	 luteus)	 To	 prepare	 inocula	 for	 bioassay,	 bacterial	
strains	were	 individually	 cultured	 for	 48	h	 in	 100	mL	 conical	
flasks	 containing	 30	 mL	 nutrient	 broth	 medium.	 Fungi	 were	
grown	 for	 7	 days	 in	 100	 mL	 conicals	 containing	 30	 mL	
Sabouraud's	dextrose	broth.	Bioassay	was	done	in	10	cm	sterile	
plastic	Petri	plates	in	which	microbial	suspension	(1	mL/plate)	
and	 15	mL	 of	 appropriate	 agar	 medium	 (15	mL/plate)	 were	
poured.	 Nutrient	 agar	 and	 Sabouraud's	 dextrose	 agar	 were	
respectively	used	 for	bacteria	and	 fungi.	After	solidification	of	
the	media,	 5	mm	 diameter	 cavities	 were	 cut	 in	 the	 solidified	
agar	 (4	 cavities/plate)	 using	 sterile	 cork	 borer.	 The	 tested	
compounds	 were	 dissolved	 in	 dimethyl	 sulfuxide	 (DMSO)	 at	
2%w:v	 (20	 mg/mL),	 pipetted	 and	 poured	 in	 the	 cavities	 (20	
µL/cavity).	 Cultures	were	 then	 incubated	 at	 28	 °C	 for	 48	h	 in	
case	of	bacteria	and	up	to	7	days	in	case	of	fungi.	Results	were	
read	 as	 the	 diameter	 (in	 mm)	 of	 inhibition	 zone	 around	
cavities.	To	determine	the	minimum	inhibitory	concentrations	
(MICs),	 several	 concentrations	 in	 DMSO	 of	 the	 compounds	
under	testing	that	gave	positive	results,	have	been	prepared	in	









The	 starting	 compound	 (8‐hydroxyquinolin‐5‐yl)(oxo)	
acetaldehyde	(2)	was	prepared	from	the	well‐known	5‐acetyl‐
8‐hydroxyquinoline	(1)	via	oxidation	with	selenium	dioxide	in	











Multi‐compo‐nent	 reaction	 of	 compound	 2,	 ethyl	
acetoacetate	3	 and	 an	 excess	 amount	 of	 hydrazine	hydrate	 in	
water	 at	 room	 temperature	 afforded	 ethyl	 6‐(8‐hydroxy	
quinolin‐5‐yl)‐3‐methyl	 pyridazin‐4‐carboxylate	 (4)	 (Scheme	
1).	 The	 structure	 of	 synthesized	 compound	4	was	 established	
by	1H	NMR,	13C	NMR,	IR,	MS	spectroscopes	in	combination	with	
elemental	 analyses.	 In	 the	 1H	 NMR	 spectrum	 of	 compound	4,	
the	 CH‐pyridazine	 ring	 is	much	 deshielded	 and	 resonating	 at	
low	 field	 and	 appear	 at	 δ	 =	 8.3	 ppm.	 The	 mass	 spectrum	 of	
compound	4	showed	its	correct	parent	ion	peak	at	m/z	309.11	
(M+,	67%)	(Scheme	1).	
The	 suggested	 mechanism	 involves	 the	 attack	 of	 enolate	
structure	5	 onto	 the	glyoxal	2,	 then	 in	 situ	generated	ethyl	2‐
acetyl‐3‐hydroxy‐4‐(8‐hydroxyquinolin‐5‐yl)‐4‐oxobutanoate	
(6),	in	the	presence	of	NH2NH2,	converts	to	compound	7	which	




of	 the	 broad	 utility	 of	 heterocyclization	 carbohydrazides	 as	
intermediates	 for	 the	 synthesis	 of	 several	 systems	 containing	
oxadiazole	and	triazole	nuclei	[26],	6‐(8‐hydroxyquinolin‐5‐yl)‐
3‐methylpyridazine‐4‐carbohydrazide	 (8)	 was	 used	 in	 prepa‐
ring	 a	 new	 series	 of	 heterocyclic	 compounds.	 The	 reaction	 of	
compound	8	with	carbon	disulphide	in	the	presence	of	ethanol	
solution	of	potassium	hydroxide	gave	 the	mercaptooxadiazole	
derivative	 9.	 The	 later	 was	 easily	 converted	 into	 the	 corres‐
ponding	 s‐alkylated	 products	 10a	 and	 10b	 upon	 treatment	
with	 ethyl	 iodide	 and/or	 benzyl	 bromide,	 respectively.	 The	
interaction	 of	 compound	 9	 with	 formaldehyde	 and	 some	




11a	 (R	 =	 Morpholine)	 displayed	 a	 singlet	 signal	 due	 to	 CH2	
protons	at	5.12	ppm.	Whereas,	compounds	11b‐d	(R	=	Primary	
aromatic	 and	 heterocyclic	 amine)	 displayed	 a	 doublet	 signals	





hydroxide	 solution	 (5%)	 yielded	 5‐[6‐(8‐hydroxyquinolin‐5‐
yl)‐3‐methylpyridazin‐4‐yl]‐4‐phenyl‐2,4‐dihydro‐3H‐1,2,4‐tri	
azole‐3‐thione	 (13).	 The	 later	 was	 converted	 into	 the	 corres‐
ponding	 s‐alkylated	 triazolo	 products	 14a	 and	 14b	 upon	
treatment	with	ethyl	iodide	and	/or	benzyl	bromide	in	ethanol	
in	 the	 presence	 of	 anhydrous	 sodium	 acetate.	 Mannich	 bases	
(15a‐d)	 were	 obtained	 from	 compound	 13	 using	 the	 former	
procedure	for	producing	compounds	11a‐d	(Scheme	3).		
The	synthesis	of	the	target	compounds	16‐21	is	depicted	in	
Scheme	 4,	 in	 which	 the	 starting	 compound	 6‐(8‐hydroxy‐
quinolin‐5‐yl)‐3‐methylpyridazine‐4‐carbohydrazide	 (8)	 was	
allowed	to	react	with	ethyl	acetoacetate	 in	ethanol	 to	produce	
the	 pyrazolinone	 derivative	 (16).	 Condensing	 of	 compound	8	
with	 acetyl	 acetone	 in	 glacial	 acetic	 acid	 gave	 rise	 to	 the	
corresponding	 (3,5‐dimethyl‐1H‐pyrazol‐1‐yl)[6‐(8‐hydroxy	
quinolin‐5‐yl)3‐methylpyridazin‐4‐yl]methanone	(17).	
Whereas,	 heating	 the	 same	 acid	 hydrazide	8	 with	 diethyl	
malonate	 at	 200	 °C	 afforded	 the	 targeted	 1‐(6‐(8‐hydroxy	
quinolin‐5‐yl)‐3‐methylpyridazine‐4‐carbonyl)	 pyrazolidine‐
3,5‐dione	 (18).	 The	 azomethine	 derivatives	 19a‐19c	 and	 20	
were	 obtained	 upon	 treatment	 of	 compound	8	with	 aromatic	
aldehydes	 in	refluxing	ethanol	 in	presence	of	catalytic	amount	




functionality.	 Thus,	 compound	 8	 when	 reacted	 with	 maleic	
anhydride	 in	 glacial	 acetic	 acid	 in	 the	 presence	 of	 anhydrous	








Using	 agar	 well‐diffusion	 method	 [27],	 thirteen	 selected	
derivatives	(4,	8,	9,	10a,	11b,	11c,	12,	13,	14a,	14b,	15b,	15c	
and	19b)	were	screened	against	Staphylococcus	aureus	(AUMC	
B.54)	 and	 Bacillus	 cereus	 (AUMC	 B.52)	 as	 Gram	 positive	
bacteria	 and	 Escherichia	 coli	 (AUMC	 B.53)	 and	 Pseudomonas	
















4	 ‐	 6 8 ‐	
8	 20	 24 25 ‐	
9	 ‐	 ‐ ‐ ‐	
10a	 16	 30 33 ‐	
11b	 ‐	 5 ‐ ‐	
11c	 ‐	 ‐ 26 30	
12	 ‐	 ‐	 ‐	 ‐	
13	 24	 34	 ‐	 ‐	
14a	 ‐	 ‐	 7	 ‐	
14b	 26	 25	 33	 23	
15b	 18	 29 26 23	
15c	 22	 32 ‐ ‐	
19b	 ‐	 5 ‐ 7	














8	 18	(2.5)	 18	(2.5) 12	(1.25) ‐	
10a	 10	(5)	 16	(5) 10	(0.15) ‐	
11c	 ‐	 ‐ 10(1.25) 9	(0.3)	
13	 9	(0.3)	 11(2.5) ‐ ‐	
14b	 13	(0.3)	 8	(1.25) 11	(1.25) 9	(0.6)	
15b	 8(0.25)	 10	(0.3) 8	(2.5) 10	(0.3)	
15c	 13	(5)	 10	(0.3)	 ‐	 ‐	
Chloramphenicol	 10	(0.08)	 12	(1.25)	 10	(0.07)	 12	(0.3)	
	
	
The	 results	 were	 recorded	 for	 each	 tested	 compound	 as	
average	 diameter	 of	 zone	 of	 inhibition	 of	 bacterial	 growth	 in	
millimeters.	Minimum	inhibitory	concentration	(MIC)	measure‐
ments	were	performed	using	agar	well	diffusion	method	(Table	
2).	 MIC	 of	 those	 compounds	 was	 determined	 which	 were	
showing	 activity	 in	 primary	 screening.	 The	 results	 of	
preliminary	 antibacterial	 testing	 of	 selected	 compounds	 are	
shown	in	Table	1	revealed	that	only	seven	compounds	8,	10a,	
11c,	 13,	 14b,	 15b	 and	 15c	 possessed	 moderate	 to	 excellent	
antibacterial	 activity	 against	 both	 Gram‐positive	 and	 Gram‐
negative	 bacteria.	 It	 was	 found	 that	 conversion	 of	 4‐ethoxy	
group	 in	 compound	4	 with	 carbohydrazide	 one	 compound	8,	
contribute	 to	 a	 good	 potency	 towards	 Gram‐positive	 bacteria	
Staphylococcus	 aureus,	 Bacillus	 cereus	 and	 against	 Gram‐
negative	 bacteria	 Escherichia	 coli	 only	 (zones	 of	 inhibition	
range	 from	 20	 to	 25	 mm)	 and	 with	 minimum	 inhibitory	
concentrations	 (MIC)	 range	 between	 2.5	 and	 1.25	 mg/mL.	
Construction	 of	 an	 thiooxadiazole	 ring	 compound	 9,	 did	 not	
display	 any	 antibacterial	 activity.	Whereas,	 the	 ethyl	 thiooxa‐
diazole	 derivative	 compound	 10a,	 exhibited	 a	 remarkable	
antibacterial	 activity	 against	 both	 Gram‐positive	 and	 Gram‐
negative	bacteria	except	towards	Pseudomonas	aeruginosa	with	
0.15	 mg/mL	 of	 MIC	 against	 Escherichia	 coli.	 However,	 the	
substituted‐3‐aminooxadiazole	 derivative	 with	 an	 electron	
donating	methoxy	group	(11c)	was	more	potent	against	Gram‐
negative	 bacteria	 (Escherichia	 coli	 and	 Pseudomonas	 aerugi‐
nosa)	 zones	 of	 inhibition	 range	 from	26	 to	 30	mm,	while	 the	
non‐substituted	one	compound	11b	was	inactive.	Construction	
of	 an	 thiotriazole	 ring	 compound	 13	 displayed	 a	 remarkable	





the	 Mannich	 bases	 15b	 and	 15c,	 compound	 15b	 with	 non‐
substituted	phenyl	group	showed	highest	activity	against	both	
Gram‐positive	 and	 Gram‐negative	 bacteria	 with	 minimum	
inhibitory	 concentrations	 (MIC)	 range	 between	 0.25	 and	 2.5	
mg/mL.	 Whereas,	 the	 derivative	 15c	 with	 an	 electron	 with‐









10a,	 11b,	 11c,	 12,	 13,	 14a,	 14b,	 15b,	 15c	 and	 19b)	 were	
screened	 for	 their	 antifungal	 activities	 against	 four	 fungal	
strains;	Candida	albicans	(AUMC	No.418),	Trichophyton	rubrum	
(AUMC	 No.	 1804),	 Aspergillus	 flavus	 (AUMC	 No.	 1276)	 and	
Fusarium	 oxysporum	 (AUMC	 No.	 5119)	 using	 Clotrimazole	 as	
control	(in	a	concentration	of	20	mg/mL).	The	results	are	listed	
in	Table	3.	It	has	been	revealed	that	mainly	five	compounds	8,	
9,	11c,	14b	 and	15c	 showed	 considerable	 antifungal	 activity	
against	 the	 tested	 fungi	 species.	 However,	 the	 4‐carbo	
hydrazide	 derivative	 (8),	 5‐[6‐(8‐hydroxyquinolin‐5‐yl)‐3‐
methyl	 pyridazin‐4‐yl]‐3‐[(4‐methoxyphenylamino)	 methyl]‐
1,3,4‐oxadiazole‐2(3H)‐thione	 derivative	 11c	 and	 its	 thio‐
triazole	 analogue	14b	 exhibited	 good	 activity	 against	Candida	
albicans,	 Aspergillus	 flavus	 and	 Fusarium	 oxysporum	 only	 in	
comparison	 with	 the	 standard	 drug	 and	 did	 not	 exhibit	
antifungal	 activity	 against	 Trichophyton	 rubrum	 and	 gave	 a	
promising	MIC,	0.08	mg/mL	against	Fusarium	oxysporum.	Also,	
the	 thiooxadiazole	 derivative	 9	 showed	 a	 moderate	 activity	
against	all	the	tested	fungi	species	except	for	Aspergillus	flavus	
(MIC,	0.08	mg/mL)	against	F.	oxysporum	(Table	3).	Finally,	the	
thio	 triazolo	 derivative	 15c	 gave	 potent	 activity	 against	
Aspergillus	 flavus	 and	 Fusarium	 oxysporum	 only	 and	 did	 not	



























8	 10	(0.3)	 ‐	 8	(0.3) 9	(1.25)	
9	 11(1.25)	 18(5) ‐ 8(0.08)	
11c	 10	(1.25)	 ‐	 9	(0.6) 8(0.08)	
14b	 12	(2.5)	 ‐	 11	(0.6)	 9(0.08)	
15c	 ‐	 ‐	 11	(0.15)	 10	(2.5)	




















































































4	 ‐	 ‐	 6 ‐	
8	 31	 ‐	 33 18	
9	 29	 39	 ‐ 16	
10a	 ‐	 ‐	 ‐ ‐	
11b	 ‐	 ‐	 ‐ ‐	
11c	 22	 ‐	 37 16	
12	 ‐	 ‐	 ‐ ‐	
13	 ‐	 ‐	 ‐	 ‐	
14a	 ‐	 ‐	 ‐	 ‐	
14b	 19	 ‐	 31 20	
15b	 ‐	 ‐	 ‐	 ‐	
15c	 ‐	 ‐	 33 26	
19b	 ‐	 ‐	 ‐ 8	
Clotrimazole	 24	 36	 45 22	
